Screener
PJP vs RWK
Invesco Pharmaceuticals ETF vs Invesco S&P MidCap 400 Revenue ETF
Key differences
- RWK costs 0.18% less per year.
- RWK is significantly larger than PJP — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, RWK has delivered higher annualized returns.
Side-by-side comparison
| PJP | RWK | |
|---|---|---|
| Annual cost (TER) | 0.57% | 0.39% |
| Fund size (AUM) | $334M | $1.2B |
| Since | 2005 | 2008 |
| Dividend yield | 1.01% | 1.16% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +40.6% | +28.8% |
| CAGR 3Y | +14.0% | +18.4% |
| CAGR 5Y | +7.8% | +10.7% |
| Sharpe 3Y | 0.69 | 0.80 |
| Volatility 1Y | 16.23% | 16.91% |
| Max drawdown | -33.95% | -46.20% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PJP and RWK
Explore further